AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 JUN 12 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - An immunization campaign to provide meningococcal C vaccine to children 0-17 years old is cost effective when the occurrence rate of disease is high.
Before the meningococcal C vaccine was available, an outbreak of meningitis could impair or kill a considerable number of children (0 to 17 years old). During the year of 1998-1999 in England and Wales, meningococcal meningitis affected approximately 1137 children, with at least 72 deaths reported.
C. L. Trotter and coauthor W. J. Edmunds at the Center of Communicable Disease Surveillance, London, analyzed the money spent on a vaccination campaign in England and Wales and compared the figures with the cost per life saved, according to a report in the British Medical Journal (Modeling cost-effectiveness of meningococcal C conjugate vaccination campaign in England and Wales, Br Med J, 2002;324(73414):809-812B).
An estimated $180 million (126 million British pounds, EUR 207 million) to $343 million (241 million British pounds, EUR 395 million) was spent on the vaccination campaign. Trotter and Edmunds approximated that the cost per life year saved equaled $8919 (6259 British pounds, EUR 10,264).
Cost effectiveness depended on mode of delivery. Costs ...
Source: HighBeam Research, Widespread meningococcal C immunization is cost effective.(Brief...